Follow-up for women after treatment for cervical cancer

Current Oncology

Volumn 17, Issue 3, 2010, Pages 65-69

  Elit, L ^a   Fyles, A W ^b   Oliver, T K ^c   Devries Aboud, M C ^c   Fung Kee Fung, M ^d  

^a JURAVINSKI CANCER CENTRE   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cervical cancer; Follow up; Practice guideline; Recurrence; Schedule; Surveillance

Indexed keywords

CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VAGINA CYTOLOGY;

EID: 77953083817     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i3.514     Document Type: Review

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Canadian Cancer Society and the National Cancer Institute of Canada. Canadian Cancer Statistics 2008. Toronto, ON: Canadian Cancer Society; 2008.
3. Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995;13:502-12.
4. Browman GP, Newman TE, Mohide EA, et al. Progress of clinical oncology guidelines development using the practice guidelines development cycle: the role of practitioner feedback. J Clin Oncol 1998;16:1226-31.
5. Elit L, Fyles AW, Devries MC, Oliver TK, Fung-Kee-Fung M on behalf of the Gynecology Cancer Disease Site Group. Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol 2009;114:528-35.
6. Ansink A, de Barros Lopes A, Naik R, Monaghan JM. Recur-rent stage ib cervical carcinoma: evaluation of the effective-ness of routine follow up surveillance. Br J Obstet Gynaecol 1996;103:1156-8.
7. Bodurka-Bevers D, Morris M, Eifel PJ, et al. Posttherapy sur-veillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 2000;78:187-93.
8. Duyn A, Van EM, Kenter G, Zwinderman K, Ansink A. Re-current cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand 2002;81:759-63.
9. Esajas MD, Duk JM, de Bruijn HW, et al. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J Clin Oncol 2001;19:3960-6.
10. Gerdin E, Cnattingius S, Johnson P, Pettersson B. Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy. Gynecol Oncol 1994;53:314-19.
11. Krebs HB, Helmkamp BF, Sevin BU, Poliakoff SR, Nadji M, Averette HE. Recurrent cancer of the cervix following radi-cal hysterectomy and pelvic node dissection. Obstet Gynecol 1982;59:422-7.
12. Larson DM, Copeland LJ, Malone JM Jr, Stringer CA, Gershenson DM, Edwards CL. Diagnosis of recurrent cervi-cal carcinoma after radical hysterectomy. Obstet Gynecol 1988;71:6-9.
13. Lim KC, Howells RE, Evans AS. The role of clinical fol-low up in early stage cervical cancer in South Wales. BJOG 2004;111:1444-8.
14. Look KY, Rocereto TF. Relapse patterns in figo stage ib carci-noma of the cervix. Gynecol Oncol 1990;38:114-20.
15. Morice P, Deyrolle C, Rey A, et al. Value of routine follow-up procedures for patients with stage i/ii cervical cancer treated with combined surgery-radiation therapy. Ann Oncol 2004;15:218-23.
16. Muram D, Curry RH, Drouin P. Cytologic follow-up of patients with invasive cervical carcinoma treated by radiotherapy. Am J Obstet Gynecol 1982;142:350-4.
17. Rintala MA, Rantanen VT, Salmi TA, Klemi PJ, Grenman SE. Pap smear after radiation therapy for cervical carcinoma. Anticancer Res 1997;17:3747-50.
18. Samlal RA, Van Der Velden J, Van Eerden T, Schilthuis MS, Gonzalez Gonzalez D, Lammes FB. Recurrent cervical carci-noma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer 1998;8:78-84.
19. Sartori E, Pasinetti B, Carrara L, Gambino A, Odicino F, Pecorelli S. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecol Oncol 2007;107(suppl 1):S241-7.
20. Soisson AP, Geszler G, Soper JT, Berchuck A, Clarke-Pearson DL. A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervi-cal carcinoma after radical hysterectomy. Obstet Gynecol 1990;76:106-9.
21. Tinga DJ, Bouma J, Boonstra H, Aalders JG. Symptomatology, localization and treatment of recurrent cervical carcinoma. Int J Gynecol Cancer 1992;2:179-88.
22. Zola P, Fuso L, Mazzola S, et al. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gyne-col Oncol 2007;107(suppl 1):S150-4.